Abstract
Purpose: To quantitatively evaluate microvascular changes in eyes with macular oedema due to branch retinal vein occlusion (BRVO) using optical coherence tomography angiography (OCTA) before and after intravitreal conbercept injection and the correlation of such changes with best-corrected visual acuity (BCVA) and retinal thickness. Methods: Twenty-eight eyes of 28 patients treated with a single intravitreal injection of conbercept for macular oedema due to BRVO were included in this study. The automatically measured values of the vessel density in the superficial (SCP) and deep retinal capillary plexus (DCP), the foveal avascular zone (FAZ) area, the FAZ perimeter, the vessel density within a 300 μm wide ring surrounding the FAZ (FD-300), the acircularity index (AI), the choriocapillaris flow area and the retinal thickness were obtained via OCTA before and at 1 month after initial injection and compared with those of age- and sex- matched healthy subjects. Results: In BRVO eyes, the vascular density in the SCP and DCP, the FD-300 and the flow area of choriocapillaris were significantly lower than those in healthy eyes, while the AI and the retinal thickness were significantly increased. After treatment, the retinal thickness in eyes with BRVO was significantly decreased in all quadrants, and the mean BCVA dramatically increased from 20/162 to 20/78 (p = 0.0017). The mean flow area of choriocapillaris significantly improved after treatment. Moreover, negative correlations between the logMAR BCVA and the whole vascular density in the SCP and DCP as well as the flow area of choriocapillaris were observed. Conclusion: OCTA enables non-invasive, layer-specific and quantitative assessment of microvascular changes in eyes with BRVO before and after treatment, and it can be used as a valuable imaging tool for the evaluation of the follow-up in BRVO patients.
References
1.
Rogers
S
, McIntosh
RL
, Cheung
N
, Lim
L
, Wang
JJ
, Mitchell
P
, et al.; International Eye Disease Consortium
. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia
. Ophthalmology
. 2010
Feb
;117
(2
):313
–9.e1
.
[PubMed]
0161-64202.
Jaulim
A
, Ahmed
B
, Khanam
T
, Chatziralli
IP
. Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature
. Retina
. 2013
May
;33
(5
):901
–10
.
[PubMed]
0275-004X3.
Li
J
, Paulus
YM
, Shuai
Y
, Fang
W
, Liu
Q
, Yuan
S
. New Developments in the Classification, Pathogenesis, Risk Factors, Natural History, and Treatment of Branch Retinal Vein Occlusion
. J Ophthalmol
. 2017
;2017
:4936924
.
[PubMed]
2090-004X4.
Qian
T
, Zhao
M
, Xu
X
. Comparison between anti-VEGF therapy and corticosteroid or laser therapy for macular oedema secondary to retinal vein occlusion: A meta-analysis
. J Clin Pharm Ther
. 2017
Oct
;42
(5
):519
–29
.
[PubMed]
0269-47275.
Cui
C
, Lu
H
. Clinical observations on the use of new anti-VEGF drug, conbercept, in age-related macular degeneration therapy: a meta-analysis
. Clin Interv Aging
. 2017
Dec
;13
:51
–62
.
[PubMed]
1176-90926.
Li
F
, Zhang
L
, Wang
Y
, Xu
W
, Jiao
W
, Ma
A
, et al. One-Year Outcome of Conbercept Therapy for Diabetic Macular Edema
. Curr Eye Res
. 2018
Feb
;43
(2
):218
–23
.
[PubMed]
0271-36837.
Xu
Y
, Rong
A
, Xu
W
, Niu
Y
, Wang
Z
. Comparison of 12-month therapeutic effect of conbercept and ranibizumab for diabetic macular edema: a real-life clinical practice study
. BMC Ophthalmol
. 2017
Aug
;17
(1
):158
.
[PubMed]
1471-24158.
Yang
W
, Tan
Y
, Li
C
, Liu
Y
, Lu
G
. Observation of curative effect of intravitreal injection of conbercept in wet age-related macular degeneration: optical coherence tomography analysis after injection
. Microsc Res Tech
. 2018
Apr
;81
(4
):384
–8
.
[PubMed]
1059-910X9.
Sun
Z
, Zhou
H
, Lin
B
, Jiao
X
, Luo
Y
, Zhang
F
, et al. EFFICACY AND SAFETY OF INTRAVITREAL CONBERCEPT INJECTIONS IN MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION
. Retina
. 2017
Sep
;37
(9
):1723
–30
.
[PubMed]
0275-004X10.
Li
F
, Sun
M
, Guo
J
, Ma
A
, Zhao
B
. Comparison of Conbercept with Ranibizumab for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion
. Curr Eye Res
. 2017
Aug
;42
(8
):1174
–8
.
[PubMed]
0271-368311.
Wakabayashi
T
, Sato
T
, Hara-Ueno
C
, Fukushima
Y
, Sayanagi
K
, Shiraki
N
, et al. Retinal Microvasculature and Visual Acuity in Eyes With Branch Retinal Vein Occlusion: Imaging Analysis by Optical Coherence Tomography Angiography
. Invest Ophthalmol Vis Sci
. 2017
Apr
;58
(4
):2087
–94
.
[PubMed]
0146-040412.
Kadomoto
S
, Muraoka
Y
, Ooto
S
, Miwa
Y
, Iida
Y
, Suzuma
K
, et al. EVALUATION OF MACULAR ISCHEMIA IN EYES WITH BRANCH RETINAL VEIN OCCLUSION: An Optical Coherence Tomography Angiography Study
. Retina
. 2018
Feb
;38
(2
):272
–82
.
[PubMed]
0275-004X13.
Winegarner
A
, Wakabayashi
T
, Fukushima
Y
, Sato
T
, Hara-Ueno
C
, Busch
C
, et al. Changes in Retinal Microvasculature and Visual Acuity After Antivascular Endothelial Growth Factor Therapy in Retinal Vein Occlusion
. Invest Ophthalmol Vis Sci
. 2018
Jun
;59
(7
):2708
–16
.
[PubMed]
0146-040414.
Novais
EA
, Waheed
NK
. Optical Coherence Tomography Angiography of Retinal Vein Occlusion
. Dev Ophthalmol
. 2016
;56
:132
–8
.
[PubMed]
0250-375115.
Hussain
N
, Hussain
A
, Zhang
M
, Su
JP
, Liu
G
, Hwang
TS
, et al. Diametric measurement of foveal avascular zone in healthy young adults using optical coherence tomography angiography
. Int J Retina Vitreous
. 2016
Dec
;2
(Oct
):27
–36
.
[PubMed]
2056-992016.
Suzuki
N
, Hirano
Y
, Yoshida
M
, Tomiyasu
T
, Uemura
A
, Yasukawa
T
, et al. Microvascular Abnormalities on Optical Coherence Tomography Angiography in Macular Edema Associated With Branch Retinal Vein Occlusion
. Am J Ophthalmol
. 2016
Jan
;161
:126
–32.e1
.
[PubMed]
0002-939417.
Rispoli
M
, Savastano
MC
, Lumbroso
B
. CAPILLARY NETWORK ANOMALIES IN BRANCH RETINAL VEIN OCCLUSION ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY
. Retina
. 2015
Nov
;35
(11
):2332
–8
.
[PubMed]
0275-004X18.
Huang
D
, Jia
Y
, Gao
SS
, Lumbroso
B
, Rispoli
M
. Optical Coherence Tomography Angiography Using the Optovue Device
. Dev Ophthalmol
. 2016
;56
:6
–12
.
[PubMed]
0250-375119.
Coscas
G
, Lupidi
M
, Coscas
F
. Image Analysis of Optical Coherence Tomography Angiography
. Dev Ophthalmol
. 2016
;56
:30
–6
.
[PubMed]
0250-375120.
Mastropasqua
R
, Toto
L
, Di Antonio
L
, Borrelli
E
, Senatore
A
, Di Nicola
M
, et al. Optical coherence tomography angiography microvascular findings in macular edema due to central and branch retinal vein occlusions
. Sci Rep
. 2017
Jan
;7
(1
):40763
.
[PubMed]
2045-232221.
Ota
M
, Tsujikawa
A
, Murakami
T
, Kita
M
, Miyamoto
K
, Sakamoto
A
, et al. Association between integrity of foveal photoreceptor layer and visual acuity in branch retinal vein occlusion
. Br J Ophthalmol
. 2007
Dec
;91
(12
):1644
–9
.
[PubMed]
0007-116122.
Noma
H
, Minamoto
A
, Funatsu
H
, Tsukamoto
H
, Nakano
K
, Yamashita
H
, et al. Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion
. Graefes Arch Clin Exp Ophthalmol
. 2006
Mar
;244
(3
):309
–15
.
[PubMed]
0721-832X23.
de Oliveira Dias
JR
, de Andrade
GC
, Novais
EA
, Farah
ME
, Rodrigues
EB
. Fusion proteins for treatment of retinal diseases: aflibercept, ziv-aflibercept, and conbercept
. Int J Retina Vitreous
. 2016
Feb
;2
(1
):3
.
[PubMed]
2056-992024.
Glacet-Bernard
A
, Sellam
A
, Coscas
F
, Coscas
G
, Souied
EH
. Optical coherence tomography angiography in retinal vein occlusion treated with dexamethasone implant: a new test for follow-up evaluation
. Eur J Ophthalmol
. 2016
Aug
;26
(5
):460
–8
.
[PubMed]
1120-672125.
Sellam
A
, Glacet-Bernard
A
, Coscas
F
, Miere
A
, Coscas
G
, Souied
EH
. QUALITATIVE AND QUANTITATIVE FOLLOW-UP USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF RETINAL VEIN OCCLUSION TREATED WITH ANTI-VEGF: Optical Coherence Tomography Angiography Follow-up of Retinal Vein Occlusion
. Retina
. 2017
Jun
;37
(6
):1176
–84
.
[PubMed]
0275-004X26.
Kang
JW
, Yoo
R
, Jo
YH
, Kim
HC
. CORRELATION OF MICROVASCULAR STRUCTURES ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY WITH VISUAL ACUITY IN RETINAL VEIN OCCLUSION
. Retina
. 2017
Sep
;37
(9
):1700
–9
.
[PubMed]
0275-004X27.
Okamoto
M
, Yamashita
M
, Sakamoto
T
, Ogata
N
. CHOROIDAL BLOOD FLOW AND THICKNESS AS PREDICTORS FOR RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION
. Retina
. 2018
Mar
;38
(3
):550
–8
.
[PubMed]
0275-004X28.
Kim
KH
, Lee
DH
, Lee
JJ
, Park
SW
, Byon
IS
, Lee
JE
. Regional Choroidal Thickness Changes in Branch Retinal Vein Occlusion with Macular Edema. Ophthalmologica Journal international d’ophtalmologie International journal of ophthalmology
. Z Augenheilkd
. 2015
;234
:109
–18
.0372-834X29.
Park
J
, Lee
S
, Son
Y
. Effects of two different doses of intravitreal bevacizumab on subfoveal choroidal thickness and retinal vessel diameter in branch retinal vein occlusion
. Int J Ophthalmol
. 2016
Jul
;9
(7
):999
–1005
.
[PubMed]
2222-395930.
Du
KF
, Xu
L
, Shao
L
, Chen
CX
, Zhou
JQ
, Wang
YX
, et al. Subfoveal choroidal thickness in retinal vein occlusion
. Ophthalmology
. 2013
Dec
;120
(12
):2749
–50
.
[PubMed]
0161-642031.
Feucht
N
, Schönbach
EM
, Lanzl
I
, Kotliar
K
, Lohmann
CP
, Maier
M
. Changes in the foveal microstructure after intravitreal bevacizumab application in patients with retinal vascular disease
. Clin Ophthalmol
. 2013
;7
:173
–8
.
[PubMed]
1177-546732.
Nagaoka
T
, Sakamoto
T
, Mori
F
, Sato
E
, Yoshida
A
. The effect of nitric oxide on retinal blood flow during hypoxia in cats
. Invest Ophthalmol Vis Sci
. 2002
Sep
;43
(9
):3037
–44
.
[PubMed]
0146-040433.
Tilton
RG
, Chang
KC
, LeJeune
WS
, Stephan
CC
, Brock
TA
, Williamson
JR
. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF
. Invest Ophthalmol Vis Sci
. 1999
Mar
;40
(3
):689
–96
.
[PubMed]
0146-040434.
Fukami
M
, Iwase
T
, Yamamoto
K
, Kaneko
H
, Yasuda
S
, Terasaki
H
. Changes in Retinal Microcirculation After Intravitreal Ranibizumab Injection in Eyes With Macular Edema Secondary to Branch Retinal Vein Occlusion
. Invest Ophthalmol Vis Sci
. 2017
Feb
;58
(2
):1246
–55
.
[PubMed]
0146-040435.
Krawitz
BD
, Mo
S
, Geyman
LS
, Agemy
SA
, Scripsema
NK
, Garcia
PM
, et al. Acircularity index and axis ratio of the foveal avascular zone in diabetic eyes and healthy controls measured by optical coherence tomography angiography
. Vision Res
. 2017
Oct
;139
:177
–86
.
[PubMed]
0042-698936.
Samara
WA
, Shahlaee
A
, Sridhar
J
, Khan
MA
, Ho
AC
, Hsu
J
. Quantitative Optical Coherence Tomography Angiography Features and Visual Function in Eyes With Branch Retinal Vein Occlusion
. Am J Ophthalmol
. 2016
Jun
;166
:76
–83
.
[PubMed]
0002-9394© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
